Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis

Carcinogenesis

Volumn 20, Issue 8, 1999, Pages 1645-1648

  Reddy, Bandaru S ^a   Kawamori, Toshihiko ^a   Lubet, Ronald ^b   Steele, Vernon ^b   Kelloff, Gary ^b   Rao, Chinthalapally V ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CARCINOGEN; METHANE; METHYL GROUP; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT; SULINDAC; THIOSULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CARCINOGENESIS; CONTROLLED STUDY; DIET; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR PROMOTION;

ADENOCARCINOMA; ADENOMA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, ALKYLATING; AZOXYMETHANE; CARCINOGENS; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG THERAPY, COMBINATION; MALE; METHYL METHANESULFONATE; RATS; RATS, INBRED F344; SULINDAC;

EID: 0032843378     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.8.1645     Document Type: Article

References (20)

1. Landis, S.H., Murray, T., Bolden, S. and Wingo, P.A. (1998) Cancer statistics 1998. CA Cancer J. Clin., 48, 6-29.
2. Potter, J.D. and Steintnetz, K. (1996) Vegetables, Fruit and Phytoestrogens as Preventive Agents, IARC Scientific Publications no. 139. IARC, Lyon, pp. 61-90.
3. Wattenberg, L.W. (1992) Chemoprevention of cancer by naturally occurring and synthetic compounds. In Wattenberg, M., Lipkin, C.W., Boone, C.W. and Kelloff, G.J. (eds) Cancer Chemoprevention. CRC Press, Boca Raton, FL, pp. 19-39.
4. Nakamaura, Y., Matsuo, T., Shimoi, K. and Tomita, I. (1993) S-methyl methane thiosulfonate, a new antimutagenic compound isolated from Brassica oleracea L. var. botrytis. Biol. Pharm. Bull., 16, 207-209.
5. Kawamori, T., Tanaka, T., Ohnishi, M., Hirose, Y., Nakamura, Y., Satoh, K., Hara, A. and Mori, H. (1995) Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding of S-methyl methane thiosulfonate in male F344 rats. Cancer Res., 55, 4053-4058.
6. Thun, M.J., Namboodiri, M.M., Calle, E.E., Flanders, W.D. and Heath, C.W. Jr (1993) Aspirin use and risk of fatal cancer. Cancer Res., 53, 1322-1327.
7. Giovannucci, E., Rimm, E.B., Stampfer, M.J., Colditz, G.A. Ascherio, A. and Willett, W.C. (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med., 121, 241-246.
8. Reddy, B.S., Rao, C.V., Rivenson, A. and Kelloff, G. (1993) Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis, 14, 1493-1497.
9. Rao, C.V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V. and Reddy, B.S. (1995) Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55, 1464-1472.
10. Reddy, B.S., Maruyama, H. and Kelloff, G. (1987) Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res., 47, 5340-5346.
11. Pollard, M., Luckert, P.H. and Schmidt, M.A. (1983) The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat. Cancer Lett., 21, 57-61.
12. Boolbol, S.K., Dannenberg, A.J., Chadbum, A. et al. (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56, 2556-2560.
13. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res., 56, 710-714.
14. Giardiello, F.M., Hamilton, S.R., Krush, A.J., Piantadosi, S., Hylind, I.M., Celano, P., Booker, S.V., Robinson, C.R. and Offerhaus, G.J. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328, 1313-1316.
15. Taketo, M.M. (1998) Cyclooxygenase-2 inhibitors in tumorigenesis (part 1). J. Natl Cancer Inst., 90, 1529-1536.
16. Rao, C.V., Tokumo, K., Rigotty, J., Zang, E., Kelloff, G. and Reddy, B.S. (1991) Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, α-difluoromethylornithine, 16α-fluoro-5-androsten-17-one and ellagic acid individually and in combination. Cancer Res., 51, 4528-4534.
17. Marnett, L.J. (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52, 5575-5589.
18. Brooks, P.M. and Day, R.O. (1991) Nonsteroidal antiinflammatory drugs-differences and similarities. N. Engl. J. Med., 324, 1716-1725.
19. Hanif, R., Pittas, A., Feng, Y., Koutos, M.I., Qiao, L, Staino-Coico, L., Shiff, S.I. and Rigas, B. (1996) Effects of nonsteroidal antiinflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52, 237-245.
20. Samaha, H.S., Kelloff, G.J., Steele, V., Rao, C.V. and Reddy, B.S. (1997) Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res., 57, 1301-1305.